Search

In an ideal, imagined world, you would not be meeting the 14 emerging leaders in healthcare we selected in these pages but in person. You could talk to Courtney Bragg, [...]

And just like that, we are in back-to-school territory. Getting children and adolescents off on the right start to their school year is among the hottest annual topics in all [...]

School is out! As children and adolescents begin their summer break, we should encourage them to go outside, start new activities, stay active, and enjoy their time off--opportunities as good [...]

The American Urological Association (AUA) recently held its 2024 annual meeting in San Antonio, Texas. As usual, the Urology Times team was onsite, delivering video and written coverage; a portion [...]

We weren't planning on having so much coverage of glucagon-like peptide 1 (GLP-1) drugs in this issue. But no matter where it starts, every conversation about managing care these days [...]

As many Contemporary Pediatrics readers likely already know from experience, there are fewer and fewer opportunities for face time with pediatric patients. Research shows pediatric primary care visits decreased nearly [...]

It's hard to imagine a disease that affects the outermost body would be greatly underestimated, but that is the situation dermatologists encounter with pediatric skin cancer. Year after year, incidence [...]

It is always a treat to review the results of Managed Healthcare Executives annual pharmacy survey and this year is no exception. CMS drug price negotiation under the Inflation Reduction [...]

Surgical complications take a considerable toll on patients and their loved ones. But they also affect the surgeons themselves. This is the subject of a poignant article in this issue [...]

Last year the Pew Research Center announced that it was tightening up how it would conduct and report on generational research. It's crucial to account for age when comparing generations, [...]

In this issue of Urology Times, Co-Editor in Chief Gopal H. Badlani, MD, offers a thoughtful and succinct editorial on the complicated issue of disposable vs reusable cystoscopes. 'The quality [...]

April is Inflammatory Bowel Syndrome (IBS) Awareness Month--another specific medical holiday that perhaps warrants a greater and more involved focus in our pediatric patients. In fact, it may surprise some [...]

The pharmacy benefit management (PBM) industry has emerged as one of the most important, interesting and perhaps controversial sectors of American healthcare. As we discuss in this issue's cover story, [...]

It has been fantastic following all the innovations being done in the non-muscle-invasive bladder cancer (NMIBC) space. In this issue, Urology Times Co-Editor in Chief Michael S. Cookson, MD, MMHC, [...]

This time of year marks our fourth anniversary since the beginning of the COVID- 19 pandemic, a global health crisis of which we may never have a confident measure to [...]

Ozempic, once a drug that only diabetes specialists and perhaps people with the disease were aware of, has become a household word. Since last year, it has been all over [...]

Given its positioning at each new year's commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed. It is rare for major new [...]

The question of when to retire from one's profession rarely comes with an easy answer. This is especially true in medicine, where age-related physical and/or cognitive decline can result in [...]

Making predictions at the beginning of the year is really kind of a fool's errand. Sure, it is cognitively comforting to think that events are going to unfold in a [...]

A new year has arrived, and with it another special health awareness day to learn about. Rare Disease Day is observed annually on February 28, except in leap years, when [...]

The past year marked significant milestones for Urology Times' Editors in Chief, Gopal H. Badlani, MD, and Michael S. Cookson, MD, MMHC, FACS. In February, Badlani was named the 2023 [...]

Our last issue of 2023 features our annual State of Industry survey, which gives us a peek into what you, our readers, are thinking about U.S. healthcare. Of course, surveys [...]

LUGPA celebrated its 15th anniversary this year, and Urology Times was in attendance in Lake Buena Vista, Florida, for full print and video coverage. The program was chock-full of clinical [...]

The full gamut of what Managed Healthcare Executive covers is on display in this issue. In our standing 'Drugs in the Pipeline' feature we keep tabs on new drugs in [...]

November is a month that resonates with a significant cause: diabetes awareness. Diabetes Awareness Month serves as a critical platform to raise awareness about diabetes, particularly in the context of [...]

A recent Urology Times Q&A interview addressed the topic of improving clinical efficiency. (1) With increasing demands on clinicians' time, ways to maximize and save that time are more important [...]

We are devoting 10 pages of this issue to our coverage of the 2023 PBMI Annual National Conference. Managed Healthcare Executive is the official publication of the meeting, and the [...]

The National Football League season began recently and, with it, the usual reporting on injuries sustained by players in the opening games. In sports, injuries deal devastating blows to teams [...]

Vaccines have had a tough crowd to contend with over the past several years. But vaccine suspicion is nothing new. In fact, skeptics abounded in 1796 when Edward Jenner developed [...]

Year in, year out, Managed Healthcare Executive's annual emerging leaders cover story is one of our favorites. One reason is the sense of optimism that comes from getting to know [...]

Welcome to Contemporary Pediatrics' annual technology issue. I can't imagine a more exciting and fertile time to be in health care, considering how fast artificial intelligence (AI) is changing the [...]

The results of Urology Times' recent survey on the uptake and usage of prostate-specific membrane antigen (PSMA)-targeting agents make for encouraging reading in terms of the adoption of this technology [...]

I am sorry.' Three short words that are long in meaning, especially in the context of medicine. No provider wants to be in the position of delivering an apology for [...]

Remember when Sovaldi (sofosbuvir), the new hepatitis C antiviral, came on the market in 2014? Its price of $84,000 for 12-week course of treatment seemed astronomical. But $84,000 for a [...]

'Work smarter, not harder' is a simple but powerful phrase and is oft-cited advice here at MJH Life Sciences. Its broad applicability extends to the practice of medicine and urology [...]

This past February, I was very proud to announce that MJH Life Sciences[R] had acquired a new company named Mesmerize. Founded in 2006, Mesmerize has developed into a premier point-of [...]

Expectations were sky-high for alternative payment models. The notion of shifting the incentives in American healthcare to reward high-quality care, prevention and cost effectiveness was attractive. Alternative payment models seemed [...]